ALLOSTATIN® is a lyophilized peptide that has a structural similarity to insect alloferons and mammalian immunoglobulins

Action mechanism

A selective activator of cytotoxic cells in the human immune system. In the presence of Allostatin®, natural killer (NK) cells more efficiently recognize and lyse tumor cells and virus-infected cells.

Method of obtaining

Allostatin® is obtained through chemical synthesis.


It is used in preparations with antiviral and antitumor activity and skin care products. Allostatin has undergone preclinical trials.

Patent of the Russian Federation No. 2267496